GX ADHERALINK
LIVE

Serial Number

79456083

Owner

Sensile Medical AG

Filing Date

Feb 25, 2026

Add to watchlist:

No watchlists yet
View on USPTO

GX ADHERALINK Trademark

Serial Number: 79456083

GX ADHERALINK is a trademark filed by Sensile Medical AG on February 25, 2026. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Sensile Medical AG (7 trademarks)

Fabrikstrasse 10

Entity Type: 99

Trademark Details

Filing Date

February 25, 2026

Registration Date

Not Registered

Goods & Services

Medical apparatus and instruments; Medical devices; medical devices for storage, preparation and/or administration of a medical substance; drug delivery devices, in particular auto-injectors, pen injectors, syringes, vials, containers; medical devices incorporating software and sensors for monitoring drug delivery, in particular smart add-on monitoring modules for drug delivery devices, smart closure systems and smart caps; medical devices featuring artificial intelligence; electronic and/or internet-enabled medical devices for transmitting drug delivery data to servers, cloud-based systems and/or electronic end devices.

Medical services; Health care services; digital medical services; medical support and consulting services; data consultation services relating to medical information; medical information and consulting services provided via general messenger apps; digital medical consulting using artificial intelligence software; therapy-accompanying care; providing medical information and patient support related to drug delivery therapies; providing healthcare advisory services via automated digital communication platforms; patient engagement services to support adherence to prescribed medical treatments; health monitoring services; health monitoring services relating to patient compliance with prescribed drug treatments; automated analysis of user and sensor data for medical purposes; data analysis for medical purposes using artificial intelligence software; health risk assessment.

Scientific and technological services; Computer software design and development; design and development of computer software for use in healthcare, medical device monitoring and patient support; design, development, maintenance, and updating of software for patient monitoring and medical device integration; hosting and cloud computing; hosting of databases and server infrastructures for patient-related drug intake data; software as a service (SaaS), platform as a service (PaaS); providing temporary use of non-downloadable software for managing medical device data and patient communications; software as a service (SaaS) for collecting, transmitting, storing, evaluating and monitoring data on medication intake; software as a service (SaaS) for the technical analysis of therapy-related user data; platform as a service (PaaS) for integrating smart medical devices with digital patient communication systems; technical data analysis; automated analysis of user and sensor data; artificial intelligence driven data analysis; provision of application programming interfaces (APIs); provision of technical interfaces (APIs) for connecting third-party applications for user-related output of information based on advice and recommendations; software for the encrypted and secure processing and transmission of medical data; provision of data protection-compliant software architectures; access control and authentication services; quality control.

Computer software; downloadable and non-downloadable software used to measure, store, collect, transmit, monitor and analyze data from drug delivery devices; software enabling automated and interactive messaging, including chatbot-based communication via third-party messaging platforms; software for integration with messaging services to enable natural language communication with patients without requiring application downloads; software for monitoring patient compliance, medication adherence, and device performance in connection with drug delivery devices; data processing programs; artificial intelligence software for healthcare; computer software for use as an application programming interface (API); wireless transmitters and receivers used with the foregoing; sensors.

Filing History

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 16, 2026 RFCR
NON-FINAL ACTION WRITTEN
Aug 15, 2026 CNRT
ASSIGNED TO EXAMINER
Aug 15, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 14, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 14, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 13, 2026 REPR